Articles with public access mandates - Joe KoopmeinersLearn more
Not available anywhere: 2
Basket designs: statistical considerations for oncology trials
AM Kaizer, JS Koopmeiners, MJ Kane, S Roychoudhury, DS Hong, ...
JCO Precision Oncology 3, 1-9, 2019
Mandates: US National Institutes of Health
Identifying optimal approaches to early termination in two-stage biomarker validation studies
AM Kaizer, JS Koopmeiners
Journal of the Royal Statistical Society Series C: Applied Statistics 66 (1 …, 2017
Mandates: US Department of Defense
Available somewhere: 106
A randomized, controlled trial of ZMapp for Ebola virus infection
Prevail II Writing Group
New England Journal of Medicine 375 (15), 1448-1456, 2016
Mandates: US National Institutes of Health, US Assistant Secretary for Preparedness …
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
RA Eeles, Z Kote-Jarai, AA Al Olama, GG Giles, M Guy, G Severi, K Muir, ...
Nature genetics 41 (10), 1116-1121, 2009
Mandates: US National Institutes of Health, Cancer Research UK
Randomized trial of reduced-nicotine standards for cigarettes
EC Donny, RL Denlinger, JW Tidey, JS Koopmeiners, NL Benowitz, ...
New England Journal of Medicine 373 (14), 1340-1349, 2015
Mandates: US National Institutes of Health
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium
Z Kote-Jarai, DF Easton, JL Stanford, EA Ostrander, J Schleutker, ...
Cancer Epidemiology Biomarkers & Prevention 17 (8), 2052-2061, 2008
Mandates: US National Institutes of Health, Cancer Research UK
Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4+ 3 and Gleason 3+ 4 tumors in a population based …
JL Wright, CA Salinas, DW Lin, S Kolb, J Koopmeiners, Z Feng, ...
The Journal of urology 182 (6), 2702-2707, 2009
Mandates: US National Institutes of Health
Mobile phone text messaging intervention for cervical cancer screening: changes in knowledge and behavior pre-post intervention
HY Lee, JS Koopmeiners, TG Rhee, VH Raveis, JS Ahluwalia
Journal of medical Internet research 16 (8), e196, 2014
Mandates: US National Institutes of Health
Effect of immediate vs gradual reduction in nicotine content of cigarettes on biomarkers of smoke exposure: a randomized clinical trial
DK Hatsukami, X Luo, JA Jensen, M Al’Absi, SS Allen, SG Carmella, ...
Jama 320 (9), 880-891, 2018
Mandates: US National Institutes of Health
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised …
WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ...
The Lancet Infectious Diseases 22 (5), 622-635, 2022
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study
I Agalliu, EM Kwon, CA Salinas, JS Koopmeiners, EA Ostrander, ...
Cancer causes & control 21, 289-300, 2010
Mandates: US National Institutes of Health
Vitamin D pathway gene variants and prostate cancer prognosis
SK Holt, EM Kwon, JS Koopmeiners, DW Lin, Z Feng, EA Ostrander, ...
The Prostate 70 (13), 1448-1460, 2010
Mandates: US National Institutes of Health
Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk
CA Salinas, E Kwon, CS Carlson, JS Koopmeiners, Z Feng, DM Karyadi, ...
Cancer Epidemiology Biomarkers & Prevention 17 (5), 1203-1213, 2008
Mandates: US National Institutes of Health
Clinical utility of five genetic variants for predicting prostate cancer risk and mortality
CA Salinas, JS Koopmeiners, EM Kwon, L FitzGerald, DW Lin, ...
The prostate 69 (4), 363-372, 2009
Mandates: US National Institutes of Health
Evaluation of protein biomarkers of prostate cancer aggressiveness
AE Rizzardi, NK Rosener, JS Koopmeiners, R Isaksson Vogel, ...
BMC cancer 14, 1-14, 2014
Mandates: US National Institutes of Health
Activation of the FGFR–STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation
LR Bohrer, P Chuntova, LK Bade, TC Beadnell, RP Leon, NJ Brady, ...
Cancer research 74 (1), 374-386, 2014
Mandates: US National Institutes of Health
Detection of prostate cancer: quantitative multiparametric MR imaging models developed using registered correlative histopathology
GJ Metzger, C Kalavagunta, B Spilseth, PJ Bolan, X Li, D Hutter, JW Nam, ...
Radiology 279 (3), 805-816, 2016
Mandates: US National Institutes of Health
mHealth pilot study: text messaging intervention to promote HPV vaccination
HY Lee, JS Koopmeiners, J McHugh, VH Raveis, JS Ahluwalia
American journal of health behavior 40 (1), 67-76, 2016
Mandates: US National Institutes of Health
Bayesian hierarchical modeling based on multisource exchangeability
AM Kaizer, JS Koopmeiners, BP Hobbs
Biostatistics 19 (2), 169-184, 2018
Mandates: US National Institutes of Health
Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features
LM FitzGerald, EM Kwon, JS Koopmeiners, CA Salinas, JL Stanford, ...
Clinical Cancer Research 15 (9), 3231-3237, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program